Related Experiment Video
Updated: May 13, 2026

Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization
Published on: September 15, 2018
MicroRNAs: a new piece in the paediatric cardiovascular disease puzzle
Ahmed Omran1, Dalia Elimam, Keith A Webster
1Department of Pediatrics and Neonatology, Suez Canal University, Ismailia, Egypt.
Insights
MicroRNAs (miRs) play a key role in pediatric cardiovascular diseases. Understanding these miRs is vital for developing new treatments and prevention strategies for children's heart conditions.
Area of Science:
- Pediatric Cardiology
- Molecular Biology
- Genetics
Background:
- Cardiovascular diseases represent a significant public health concern in children.
- MicroRNAs (miRs) are increasingly recognized for their involvement in cardiac development, function, and disease.
- Current understanding of miR roles in pediatric cardiovascular conditions is limited.
Purpose of the Study:
- To review the current literature on the role of microRNAs (miRs) in pediatric cardiovascular diseases.
- To highlight the importance of miR-based research for understanding disease pathogenesis.
- To encourage further investigation into novel preventive and therapeutic strategies targeting miRs in pediatric cardiology.
Main Methods:
- Comprehensive literature review of studies investigating microRNAs in pediatric cardiovascular disorders.
- Analysis of existing research on miR involvement in heart development and function.
- Synthesis of findings related to specific pediatric cardiovascular conditions and their associated miRs.
Main Results:
- MicroRNAs are implicated in various aspects of pediatric heart development and disease.
- Specific miRs have been identified as potential biomarkers and therapeutic targets in conditions like congenital heart defects and cardiomyopathies.
- Further research is needed to fully elucidate the complex roles of miRs.
Conclusions:
- MicroRNA research offers promising avenues for improving diagnosis, treatment, and prevention of pediatric cardiovascular diseases.
- Targeting miRs could lead to enhanced cardiac development and improved clinical outcomes for affected children.
- Continued investigation into miR-based therapies is crucial for reducing morbidity and mortality in pediatric cardiology.
Abstract:
Cardiovascular diseases in children comprise a large public health problem. The major goals of paediatric cardiologists and paediatric cardiovascular researchers are to identify the cause(s) of these diseases to improve treatment and preventive protocols. Recent studies show the involvement of microRNAs (miRs) in different aspects of heart development, function, and disease. Therefore, miR-based research in paediatric cardiovascular disorders is crucial for a better understanding of the underlying pathogenesis of the disease, and unravelling novel, efficient, preventive, and therapeutic means. The ultimate goal of such research is to secure normal cardiac development and hence decrease disabilities, improve clinical outcomes, and decrease the morbidity and mortality among children. This review focuses on the role of miRs in different paediatric cardiovascular conditions in an effort to encourage miR-based research in paediatric cardiovascular disorders.
Related Concept Videos
MicroRNAs
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Rheumatic Heart Disease I: Introduction
